Table 3.
Agreement between OPN expression and each of cytoplasmic β-catenin, nuclear β-catenin and combined cytoplasmic and nuclear β-catenin expression in CRC cases (n = 72)
| OPN | Kappa | P | Sig | ||
|---|---|---|---|---|---|
|
|
|||||
| Positive | Negative | ||||
|
| |||||
| n (%) | n (%) | ||||
|
| |||||
| 33 (45.83) | 39 (54.17) | ||||
| Cytoplasmic β-catenin | |||||
| Positive (n = 38) | 23 (60.53) | 15 (39.47) | 0.309 | 0.01 | HS |
| Negative (n = 34) | 10 (29.41) | 24 (70.59) | |||
| Nuclear β-catenin | |||||
| Positive (n = 23) | 22 (95.65) | 1 (4.35) | 0.656 | 0.0001 | HS |
| Negative (n = 49) | 11 (22.45) | 38 (77.55) | |||
| Combined cytoplasmic and nuclear β-catenin | |||||
| Present (n =16) | 16 (100.00) | 0 (0.00) | 0.505 | 0.0001 | HS |
| Absent (n = 56) | 17 (30.36) | 39 (69.64) | |||